Literature DB >> 17222679

Improvement in bladder storage function by tamsulosin depends on suppression of C-fiber urethral afferent activity in rats.

Osamu Yokoyama1, Anwar Yusup, Nobuyuki Oyama, Yoshitaka Aoki, Yoshiji Miwa, Hironobu Akino.   

Abstract

PURPOSE: Alpha(1)-blockers improve voiding symptoms by decreasing prostatic and urethral smooth muscle tone. However, to our knowledge the mechanism underlying improvements in storage symptoms is not known. Topical application of prostaglandin E(2) to the rat lower urinary tract stimulates the micturition reflex. Using an animal model we investigated whether the alpha(1)-blocker tamsulosin (Astellas Pharma, Tokyo, Japan) acts on C-fiber afferent activity and, if so, the location of this effect.
MATERIALS AND METHODS: To induce desensitization of C-fiber afferent activity resiniferatoxin (0.3 mg/kg) was subcutaneously injected in female Sprague-Dawley rats 2 days before experiments. Simultaneous recordings of urethral pressure and rhythmic bladder pressure were made with the rats under urethane anesthesia. Prostaglandin E(2) (0.4 mg/ml) was continuously administered intravesically or intraurethrally to rats pretreated with resiniferatoxin (resiniferatoxin rats) or rats without pretreatment (nonresiniferatoxin rats). We investigated the effects on the micturition reflex of intravenous (2.2 x 10(-1) to 2.2 x 10(3) nM/kg) or intrathecal (0.001 to 0.1 nmol) administration of tamsulosin.
RESULTS: The bladder contraction interval was markedly decreased after intravesical or intraurethral administration of prostaglandin E(2) in nonresiniferatoxin rats but it was unchanged in resiniferatoxin rats. This effect was antagonized by the EP1 receptor antagonist ONO-8711 (6-[(2S,3S)-3-(4-chloro-2-methylphenylsulfonylaminomethyl)-bicyclo[2.2.2]octan-2-yl]-5Z-hexenoic acid). Intravenous administration of tamsulosin significantly increased the bladder contraction interval in nonresiniferatoxin rats receiving intraurethral prostaglandin E(2) but it had no effect on nonresiniferatoxin rats receiving intravesical prostaglandin E(2). Intrathecal administration of tamsulosin produced a slight and insignificant increase in the bladder contraction interval in nonresiniferatoxin rats receiving intraurethral prostaglandin E(2).
CONCLUSIONS: These results suggest that prostaglandin E(2) enhances the micturition reflex through C-fiber afferents and tamsulosin had an inhibitory effect on the C-fiber urethral afferent nerves, thereby improving bladder storage function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17222679     DOI: 10.1016/j.juro.2006.09.076

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

Review 1.  Alpha1-adrenoceptor subtypes and lower urinary tract symptoms.

Authors:  Debra A Schwinn; Claus G Roehrborn
Journal:  Int J Urol       Date:  2008-03       Impact factor: 3.369

2.  Pathophysiology of the urothelium and detrusor.

Authors:  Pradeep Tyagi
Journal:  Can Urol Assoc J       Date:  2011-10       Impact factor: 1.862

3.  The pressure flow study investigation of pathophysiology of post-micturition dribble in male patients.

Authors:  Mamoru Hashimoto; Nobutaka Shimizu; Saizo Fujimoto; Ken Kuwahara; Mitsuhisa Nishimoto; Shogo Adomi; Eri Banno; Takafumi Minami; Kazutoshi Fujita; Kazuhiro Yoshimura; Akihide Hirayama; Hirotsugu Uemura
Journal:  Int Urol Nephrol       Date:  2022-09-20       Impact factor: 2.266

4.  Selective α1A-blocker improves bladder storage function in rats via suppression of C-fiber afferent activity.

Authors:  Osamu Yokoyama; Hideaki Ito; Yoshitaka Aoki; Nobuyuki Oyama; Yoshiji Miwa; Hironobu Akino
Journal:  World J Urol       Date:  2009-10-16       Impact factor: 4.226

Review 5.  Does anticholinergic medication have a role in treating men with overactive bladder and benign prostatic hyperplasia?

Authors:  Kyu-Sung Lee; Hye Won Lee; Deok Hyun Han
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-01-03       Impact factor: 3.000

6.  OAB without an overactive bladder in the acute prostaglandin E2 rat model.

Authors:  James A Hokanson; Christopher L Langdale; Arun Sridhar; Warren M Grill
Journal:  Am J Physiol Renal Physiol       Date:  2017-08-02

7.  Effects of Spinal and Peripheral Injection of α1A or α1D Adrenoceptor Antagonists on Bladder Activity in Rat Models with or without Bladder Outlet Obstruction.

Authors:  Jae Heon Kim; Ji Sung Shim; Seung Chul Kang; Kang Soo Shim; Jae Young Park; Du Geon Moon; Jeong Gu Lee; Jae Hyun Bae
Journal:  Int Neurourol J       Date:  2011-12-31       Impact factor: 2.835

8.  Afferent Pathway-Mediated Effect of α1 Adrenergic Antagonist, Tamsulosin, on the Neurogenic Bladder After Spinal Cord Injury.

Authors:  Jin-Hee Han; Sung-Eun Kim; Il-Gyu Ko; Jayoung Kim; Khae Hawn Kim
Journal:  Int Neurourol J       Date:  2017-09-12       Impact factor: 2.835

9.  Detrusor Overactivity May Be a Prognostic Factor for Better Response to Combination Therapy Over Monotherapy in Male Patients With Benign Prostatic Enlargement and Storage Lower Urinary Tract Symptoms.

Authors:  Vasileios Sakalis; Vasileios Sfiggas; Ioannis Vouros; George Salpiggidis; Athanasios Papathanasiou; Apostolos Apostolidis
Journal:  Int Neurourol J       Date:  2020-12-31       Impact factor: 2.835

10.  Efficacy and safety of onabotulinumtoxinA in patients with overactive bladder: subgroup analyses by sex and by serum prostate-specific antigen levels in men from a randomized controlled trial.

Authors:  Osamu Yokoyama; Masashi Honda; Tomonori Yamanishi; Yuki Sekiguchi; Kenji Fujii; Kyoko Kinoshita; Takashi Nakayama; Akikazu Ueno; Takao Mogi
Journal:  Int Urol Nephrol       Date:  2021-07-22       Impact factor: 2.370

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.